跳至主要内容
临床试验/TCTR20240608003
TCTR20240608003招募中4 期

Efficacy and Safety of Intravenous Tranexamic Acid on Perioperative Blood Loss in Spinal Metastasis Decompressive Surgery: A Double-blinded, Randomized, Placebo-controlled Trial

Department Orthopaedic Surgery, Mahidol University Faculty of Medicine Siriraj Hospital0 个研究点目标入组 108 人开始时间: 2024年6月8日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
108

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 N/A (No limit)(—)
性别
All

入选标准

  • Patients with metastatic spinal cord compression at the Thoracolumbar spine who have undergone laminectomy and instrumentation surgery.

排除标准

  • 1. Patients who have not stopped antiplatelet or anticoagulant medication prior to surgery.
  • 2. Presence of coagulopathy.
  • 3. Platelet level less than 50,000
  • 4. History of allergy to Tranexamic acid or contraindications to its use.
  • 5. History of venous thromboembolic events.
  • 6. Serum creatinine level more than and equal 2.5

研究者

发起方
Department Orthopaedic Surgery, Mahidol University Faculty of Medicine Siriraj Hospital

相似试验